Northsea Therapeutics

Developer of structurally engineered fatty acids for metabolic disease treatment

placeNaarden, North Holland, Netherlands calendar_todayFounded 2017 groups4 employees language northseatherapeutics.com

Social engagement

Social engagement: 1.5K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include VenBio, BioGeneration Ventures, Forbion, Ysios Capital.

Investor typeCountShare
Venture capital770%
Bank & private debt110%
Other / undisclosed220%

Recent activity

2 May 2026
Event
BioEquity Europe 2026
14 Apr 2026
Leadership hire
Board of Directors
3 Mar 2026
Milestone
regulatory
Coming soon